News
FDA investigates secondary cancers from CAR T-cell therapies
The agency is evaluating the need for regulatory action on the links between CAR T-cell immunotherapies and secondary blood cancers.
News
FDA OKs capivasertib for certain advanced breast cancers
The FDA also approved a companion diagnostic device, the FoundationOne CDx assay, to identify patients who are eligible for treatment with...
News
FDA approves first tx for rare, deadly clotting disorder
First drug to treat TTP. a rare, lethal blood clotting disorder, has been greenlighted by the FDA.
News
Prior authorizations interfere with recommended cancer care
Policy interventions and advocacy efforts at the patient, clinician, and hospital level will be needed to reform the PA process.
News
T-DXd benefits persist for HER2-low breast cancer
Extended follow-up of DESTINY-Breast04 confirms survival benefit of T-DXd for HER2-low advanced breast cancer.
News
ALK inhibitor alectinib shows DFS benefit in early NSCLC
Interim findings from the ALINA trial show improved DFS with alectinib in the adjuvant setting vs. chemotherapy in resected stage IB-IIIA NSCLC....
News
Perioperative nivolumab improves EFS in resectable NSCLC
Interim findings from CheckMate 77T show an overall improvement in event-free survival with perioperative nivolumab vs. neoadjuvant nivolumab plus...
News
FDA approves nivolumab for resected stage IIB/C melanoma
Approval was based on findings from a phase 3 trial, which randomly assigned 790 patients to receive nivolumab or placebo by intravenous infusion...
News
What the first authorized DNA cancer risk test can and can’t tell you
The test can identify genetic variants that increase an individual’s risk of certain cancers and help identify potential cancer-related hereditary...
News
MOC opposition continues to gain momentum as ASH weighs in
“ASH continues to support the importance of lifelong learning for hematologists via a program that is evidence-based, relevant to one’s practice,...
News
NCCN survey shows ongoing chemo drug shortages
“These new survey results remind us that we are still in an ongoing crisis and must respond with appropriate urgency.”
News
Advanced practice radiation therapists: Are they worth it?
The APRT role helps reduce physician burnout and optimize patient experience.
News
Discussing family history post–genetic testing may prevent breast cancer overtreatment
A first-degree family history confers higher cancer risk, thus family history should be taken into consideration to limit exposing lower-risk...
News
Survey: Lack of awareness hampers cancer prevention efforts
Various guidelines that address physicians' role in patient awareness and knowledge focus on assessing patient needs and readiness to learn,...
News
No link between most cancers and depression/anxiety: Study
The findings “may help health professionals to alleviate feelings of guilt and self-blame in patients with cancer who attribute their diagnosis to...